Abstract
BACKGROUND: During sedation for upper gastrointestinal endoscopy, oxygen delivery via a nasal cannula is often necessary. However, the influences of the oxygen delivery route and breathing pattern on the FIO2 have not been thoroughly investigated. The aim of this simulation study was to investigate the difference in the FIO2 with a pharyngeal cannula versus nasal cannula during high- or low-tidal volume (VT) ventilation and open- or closed-mouth breathing.
METHODS: Six healthy volunteers were asked to breathe using 2 patterns of ventilation (high or low VT) via a sealed face mask connected to an endotracheal tube that was retrogradely inserted into the trachea of a mannequin. The mannequin also had a pharyngeal or nasal cannula inserted into the pharynx or attached to the nose, through which oxygen (2 or 5 L/min) was delivered. The mouth of the mannequin was kept open or closed by packing. We measured the FIO2 of every breath for 1 min at each setting.
RESULTS: During low- and high-VT ventilation, the FIO2 was highest at a flow of 5 L/min with a pharyngeal cannula. Oxygen delivery was higher with the pharyngeal cannula compared with the nasal cannula at all settings. Differences in flow did not result in significant differences in the FIO2 with high- and low-VT ventilation. At a flow of 5 L/min via a pharyngeal cannula, open-mouth breathing resulted in a significantly higher FIO2 compared with closed-mouth breathing.
Conclusions: A pharyngeal cannula provided a higher FIO2 compared with a nasal cannula at the same oxygen flow. Open-mouth breathing resulted in a higher FIO2 compared with closed-mouth breathing when 5 L/min oxygen was delivered via a pharyngeal cannula. The breathing pattern did not affect the FIO2 in this study.
Introduction
During procedural sedation for upper gastrointestinal endoscopy or any other invasive procedure, oxygen delivery via a nasal cannula is frequently necessary to prevent hypoxia. However, according to American Thoracic Society recommendations, the oxygen flow of a nasal cannula is limited to 5 L/min.1
Generally, an oxygen flow of 5 L/min can provide an FIO2 of no more than 0.50.2–4 Besides oxygen flow, the FIO2 depends on several other factors, such as breathing pattern and volume of the oral cavity as an oxygen reservoir. Additionally, sedative drugs have been shown to induce changes in the breathing pattern. Opioids cause high-tidal volume (VT) and low-breathing frequency patterns.5 Benzodiazepines and propofol cause low-VT and high-breathing frequency patterns.6,7 Although some reports have measured the FIO2 during oxygen delivery via a nasal cannula,2,4,8 the influence of breathing pattern on the FIO2 has not been investigated.
Oxygen delivery via a pharyngeal cannula results in the oxygen being placed closer to the trachea compared with a nasal cannula. It has been suggested that use of a pharyngeal cannula may provide a higher FIO2.9
The FIO2 also depends on whether the mouth of the patient is open or closed while breathing. Some studies found no significant difference in the FIO2 between open- and closed-mouth breathing,2,10 whereas another study found higher oxygen fractions during open-mouth versus closed-mouth breathing.4
The aim of this simulation study was to investigate the changes in the FIO2 during high- and low-VT ventilation when oxygen is provided via a pharyngeal cannula rather than a nasal cannula using a mannequin and spontaneously breathing healthy volunteers.
QUICK LOOK
Current knowledge
Low-flow oxygen is commonly delivered using a nasal cannula at a flow <6 L/min. In this flow range, patient breathing pattern can impact the delivered FIO2. The pharyngeal catheter is not commonly used owing to issues of patient discomfort. Low-flow oxygen therapy with any appliance is complicated by changes in tidal volume and breathing frequency.
What this paper contributes to our knowledge
In a model system, a pharyngeal catheter provided higher FIO2 than a nasal cannula at the same oxygen flow. Open-mouth breathing resulted in a higher FIO2 than closed-mouth breathing when 5 L/min oxygen was delivered via a pharyngeal catheter. The breathing pattern did not affect FIO2 in this study.
Methods
The local ethics committee approved this study, and we obtained written informed consent from each subject. Six healthy volunteers (25–48 y old) participated in this study. Each participant was asked to breathe using 2 patterns of ventilation: high VT (700–800 mL, breathing frequency of 12 breaths/min, and inspiratory-expiratory ratio of 1:1 and low VT (350–400 mL, breathing frequency of 24 breaths/min, and inspiratory-expiratory ratio of 1:1 via a sealed face mask connected to an endotracheal tube (8.0-mm inner diameter, Hi-Lo tracheal tube, Mallinckrodt, Neunkirchen-Seelscheid, Germany) that was retrogradely inserted into the trachea of a mannequin (SimMan, Laerdal Medical, Stavanger, Norway) (Fig. 1). VT was measured with a flow meter (Haloscale standard respirometer, Wright, United Kingdom) placed near the face mask. The mouth of the mannequin was opened or closed by packing and sealing. After a nasal cannula was attached to the mannequin's nose or an 8 French pharyngeal cannula was inserted through the nose into its pharyngeal space, the oxygen flow was adjusted to 2 or 5 L/min. In addition, for the pharyngeal cannula, an oxygen flow of 10 L/min was also studied to measure the maximum FIO2 in an emergency setting. Before the start of each measurement, participants were asked to breathe for >3 min as preparation to stabilize the FIO2. We used a gas analyzer (AG-920R multigas unit, Nihon Kohden, Tokyo, Japan) to measure the FIO2 of every breath by obtaining samples from near the sealed face mask using a side-flow method for 1 min at each setting. With this method, the FIO2 of exhaled gas could be distinguished from that of inhaled gas. Following data collection for 1 min, each participant was asked to breathe at a new setting. This process was repeated at oxygen flows of 2 and 5 L/min (Fig. 2). After an interval of >30 min, the same process was repeated with other oxygen supply devices (nasal or pharyngeal cannula), position of mouth (open or closed), and breathing patterns (high or low VT).
The data for the FIO2 at each setting were expressed as mean ± SD and analyzed by 2-way analysis of variance and the Tukey test as a post hoc test using SPSS (SPSS, Chicago, Illinois). P < .05 was considered statistically significant.
Results
In this study, the volume of the space from the retrogradely intubated tube to the face mask was ∼60 mL. All participants could breathe as expected.
Pharyngeal Versus Nasal Cannula
With open-mouth low- and high-VT ventilation settings, the FIO2 was highest with a pharyngeal cannula at a flow of 5 L/min (0.63 ± 0.06 and 0.64 ± 0.07, respectively) and lowest with a nasal cannula at a flow of 2 L/min (0.32 ± 0.02 and 0.32 ± 0.02, respectively) (Figs. 3 and 4). This trend was also observed with closed-mouth settings (Figs. 5 and 6). At the same oxygen flow with open-mouth settings, the pharyngeal cannula (0.38 ± 0.04 at low VT and 0.39 ± 0.05 at high VT with 2 L/min oxygen, 0.63 ± 0.06 at low VT and 0.64 ± 0.07 at high VT with 5 L/min oxygen) showed a significantly higher FIO2 than the nasal cannula (0.32 ± 0.02 at low VT and 0.32 ± 0.02 at high VT with 2 L/min oxygen, 0.51 ± 0.06 at low VT and 0.54 ± 0.05 at high VT with 5 L/min oxygen, P < .05). This was also true with closed-mouth settings (pharyngeal cannula: 0.36 ± 0.04 at low VT and 0.38 ± 0.05 at high VT with 2 L/min oxygen, 0.57 ± 0.07 at low VT and 0.61 ± 0.08 at high VT with 5 L/min oxygen; nasal cannula: 0.33 ± 0.03 at low VT and 0.32 ± 0.04 at high VT with 2 L/min oxygen, 0.49 ± 0.06 at low VT and 0.51 ± 0.08 at high VT with 5 L/min oxygen, P < .05).
With both low- and high-VT settings during open-mouth breathing, the FIO2 at a flow of 5 L/min via a nasal cannula (0.51 ± 0.06 for a low tidal setting, 0.54 ± 0.05 for a high tidal setting) was significantly higher than that at a flow of 2 L/min via a pharyngeal cannula (0.39 ± 0.05 for a high tidal setting, 0.38 ± 0.04 for a low tidal setting, P < .01). This was also true with closed-mouth settings.
High Versus Low VT
With both nasal and pharyngeal cannulas and the open- and closed-mouth settings, VT had no effect on the FIO2 at the same oxygen flow (Figs. 7 and 8).
Open Versus Closed Mouth
Open-mouth breathing resulted in a significantly higher FIO2 than closed-mouth breathing when using the pharyngeal cannula at low VT (0.38 ± 0.04 vs 0.36 ± 0.04 with 2 L/min oxygen, P = .02; 0.63 ± 0.06 versus 0.57 ± 0.07 with 5 L/min oxygen, P < .01). During high-VT ventilation, a significant difference was observed only with 5 L/min oxygen: 0.32 ± 0.02 vs 0.32 ± 0.04 with 2 L/min oxygen (the difference was not significant) and 0.64 ± 0.07 vs 0.61 ± 0.08 with 5 L/min oxygen (P = .04) (Figs. 9 and 10). With low- and high-VT ventilation settings and open- and closed-mouth breathing, 10 L/min oxygen flow via a pharyngeal cannula provided the highest oxygen fraction (0.80 ± 0.07 and 0.78 ± 0.07 with open-mouth breathing, 0.79 ± 0.09 and 0.78 ± 0.07 with closed-mouth breathing) (Table 1).
Discussion
In this study, we found that a pharyngeal cannula provided a higher FIO2 than a nasal cannula at the same oxygen flow during both open- and closed-mouth breathing. Compared with a nasal cannula, oxygen was delivered close to the trachea with a pharyngeal cannula, thus minimizing dilution of the oxygen with air. Eastwood et al9 reported that nasopharyngeal oxygen supplementation via a 10 French catheter inserted just behind the soft palate required a lower oxygen flow compared with a face mask to maintain oxygen saturation. Transtracheal catheters were also reported to be more effective than nasal cannulas at the same oxygen flow in a previous study.3
In addition, the cavity of the pharynx serves as a large oxygen reservoir in the pharyngeal cannula setting. The size of the reservoir might also affect the difference in the FIO2 between nasal and pharyngeal cannulas. Whether the mouth was open or closed during supplemental oxygen administration was previously reported to affect the FIO2. Wettstein et al4 reported that the FIO2 was significantly higher with an open mouth compared with a closed mouth in healthy volunteers with nasal cannulas. Kory et al10 reported that open-mouth breathing resulted in oxygen concentrations similar to or higher than those obtained with closed-mouth breathing. These reports all speculated that the larger oral cavity resulted in an increase in the FIO2 by serving as an oxygen reservoir. The results of the present study seem to support the findings of previous studies. Open-mouth breathing results in a larger oral and pharyngeal space, which increases the size of the oxygen reservoir. Oxygen administration via a pharyngeal cannula might contribute to the oxygen reservoir formation.
It is commonly believed that the effectiveness of low-flow oxygen supply systems is affected by the patient's breathing pattern, which makes the actually delivered FIO2 unstable.4 In this study, we abolished this factor by fixing breathing pattern using a flow meter. With both nasal and pharyngeal cannulas, the magnitude of the VT had no significant influence on the FIO2. Contrary to our initial hypothesis that breathing pattern (including VT and frequency) might affect the FIO2 because of changes in dead space and the effect of rebreathing, our results suggested that breathing pattern might not influence oxygen delivery. Opioids tend to increase VT and decrease breathing frequency.5 On the other hand, benzodiazepines and propofol tend to decrease VT and increase breathing frequency.6,7 Our results seem to suggest that the choice of sedative drugs is not likely to significantly affect the FIO2 in sedated patients.
An oxygen flow of 10 L/min administered via a pharyngeal cannula increased the FIO2 to as high as 0.80. In addition, PEEP might be generated by the high flow of oxygen.11 Our results may find application in emergency situations of severe hypoxia, where 10 L/min oxygen delivered via a pharyngeal cannula may prove to be an easy and helpful method for oxygenation.
This study has several limitations. First, the participants' respiratory dead spaces were enlarged by a volume equal to the area from the mannequin's pharyngeal space to the face mask. The volume of this space was at least 60 mL. Dead space from the pharyngeal space of the mannequin to the face mask was significantly larger than the participants' actual dead space volume.
Second, although this study showed the efficacy of a pharyngeal cannula during procedural sedation, the fact that the pharyngeal cannula administers dry gases directly to the pharynx may be a problem. No humidifying devices (such as a bubble humidifier) was used in this study because those devices might not commonly be used in upper gastrointestinal endoscopy patients. Dry-gas administration can cause airway complications, such as ciliary dysfunction, airway injury, atelectasis, and pneumonia.12–14 A pharyngeal cannula may be slightly more invasive than a nasal cannula, and local adverse effects have not been evaluated. Hence, clinical evaluation is necessary to confirm the safety of oxygen administration via a pharyngeal cannula and the necessity of humidifying devices. The fraction of expired oxygen might affect the FIO2, but it was not measured in this study.
Another limitation of this study is that the mannequin breathed via both mouth and nose in open-mouth settings. In contrast, patients can breathe through their noses or mouths with their mouths open. We did not study the situation in which the mannequin breathed only through the mouth because it is inappropriate to evaluate the effect of oxygen supplementation via a nasal or pharyngeal cannula in such a setting.
Conclusions
A pharyngeal cannula provided a higher FIO2 than a nasal cannula at the same oxygen flow during open- and closed-mouth breathing in this study. Oxygen administration via a pharyngeal cannula rather than a nasal cannula might be clinically useful in sedated patients, who are likely to need a higher FIO2 to prevent severe hypoxia. The breathing pattern did not influence the FIO2 in this study.
Footnotes
- Correspondence: Tetsuya Miyashita MD, Department of Anesthesiology, Yokohama City University Hospital, 3–9 Fukuura Kanazawa, Yokohama City 236-0004, Japan. E-mail: yushukyo{at}gmail.com.
The authors have disclosed no conflicts of interest.
- Copyright © 2015 by Daedalus Enterprises